Wellington Biomedical Innovation Master Investors (Cayman) II L.P. insider trades
Wellington Biomedical Innovation Master Investors (Cayman) II L.P. has filed 6 Form 4s with the SEC that we hold, for Avalyn Pharma Inc. (AVLN) (10% owner), CRGX (10% owner), MBX Biosciences, Inc. (MBX) (10% owner) and MTSR (10% owner), among 6 companies in all. None of these filings reports a purchase (code P) or sale (code S) of common stock; they cover grants, option exercises and other codes. The first filing on our record is dated 2023-09-19 and the latest 2026-05-01.
Avalyn Pharma Inc. (AVLN)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
CRGX
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
MBX Biosciences, Inc. (MBX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
MTSR
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
RYZB
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Upstream Bio, Inc. (UPB)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1903360) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms